Parkman Healthcare Partners LLC Harvard Bioscience Inc Transaction History

Parkman Healthcare Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $108,105 - $181,876	-46,397 Reduced 13.19%	305,353 $782,000
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.42 $925,209 - $1.81 Million	-282,076 Reduced 44.5%	351,750 $1.27 Million
Q1 2022 May 13, 2022	BUY	$5.16 - $7.14 $499,204 - $690,759	96,745 Added 18.01%	633,826 $3.94 Million
Q4 2021 Feb 11, 2022	BUY	$6.37 - $8.18 $393,118 - $504,820	61,714 Added 12.98%	537,081 $3.79 Million
Q3 2021 Nov 12, 2021	BUY	$6.98 - $8.47 $509,540 - $618,310	73,000 Added 18.14%	475,367 $3.32 Million
Q2 2021 Aug 13, 2021	BUY	$5.44 - $8.4 $2.19 Million - $3.38 Million	402,367 New	402,367 $3.35 Million

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.